Clinical Trial

Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is being done to demonstrate the effectiveness of Regenerative Peripheral Nerve Interfaces (RPNI) surgery in treating symptomatic neuromas of the hand and digits following amputation compared to standard of care using a Prospective, Observational Trial
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-08-09; most recent amendment 2024-11-26.
Status change: Not Yet Recruiting → Recruiting 2021-10-19
Trial Details
NCT Number NCT05008185
Lead Sponsor Medstar Health Research Institute
Collaborators: United States Department of Defense, University of Michigan
Conditions Neuroma
Enrollment 80 participants
Start Date 2021-10-05
Primary Completion 2025-08 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2024-11-29